ClinicalTrials.Veeva

Menu

Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function

P

Palo Alto Veterans Institute for Research

Status

Completed

Conditions

Hemodialysis
Kidney Failure, Chronic

Treatments

Other: Twice Weekly Hemodialysis then Thrice Weekly Hemodialysis
Other: Thrice Weekly Hemodialysis then Twice Weekly Hemodialysis

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03874117
SIT0003AGG
R01DK118426 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The study will determine the efficacy of twice weekly hemodialysis in patients with residual kidney function.

Full description

Hemodialysis patients who have residual kidney function will undergo two 4-week study (twice weekly versus thrice weekly hemodialysis) using a cross-over design. Blood, urine, and dialysate samples will be collected at the end of each study period to determine adequacy of treatment and to assess uremic solute levels. Participants will complete quality of life questionnaires and cognitive paper tests.

Enrollment

58 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients on hemodialysis who have residual kidney function with residual urea clearance (Kru) >2.5 mL/min.
  • been on hemodialysis for at least 3 months.
  • adherence to regular dialysis treatments.

Exclusion criteria

  • inability to achieve adequate hemodialysis.
  • planned revision of hemodialysis vascular access.
  • hospitalized within the past 2 months.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

58 participants in 2 patient groups

Twice Weekly Hemodialysis then Thrice Weekly Hemodialysis
Other group
Description:
Twice weekly hemodialysis for 4 weeks, then thrice weekly hemodialysis for 4 weeks.
Treatment:
Other: Twice Weekly Hemodialysis then Thrice Weekly Hemodialysis
Thrice Weekly Hemodialysis then Twice Weekly Hemodialysis
Other group
Description:
Thrice weekly hemodialysis for 4 weeks, then twice weekly hemodialysis for 4 weeks.
Treatment:
Other: Thrice Weekly Hemodialysis then Twice Weekly Hemodialysis

Trial documents
2

Trial contacts and locations

3

Loading...

Central trial contact

Saniya Bonde, BS; Tammy Sirich, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems